Merck won FDA approval for a shot that protects against RSV, the most common cause of hospitalization among infants ...

Researchers sought to determine whether a real-time personalized algorithm may help to effectively plan HDMTX infusion among pediatric patients with ALL.

Experts recommend earlier dosing of measles vaccines to protect infants from fast-spreading outbreaks, as most babies lose ...

The simplicity of Merck's monoclonal antibody for RSV in infants could be a plus in its competition with AstraZeneca's ...

Clesrovimab joins the monoclonal antibody nirsevimab (Beyfortus), as well as the maternal bivalent RSV prefusion F protein ...